EFFECT OF CRYOLIPOLYSIS ON HORMONAL PROFILE AND MENSTRUAL REGULARITYIN OBESE WITH PCOS
Launched by SABRIN MOHAMED TAHA ABDELWAHAB · Jan 18, 2024
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Polycystic ovary syndrome(PCOS) is the most common endocrine disorder in women of reproductive age. Women with this syndrome may have infrequent menstrual periods or amenorrhea and excess androgen levels. The ovaries develop numerous small follicles and fail to ovulate on a regular basis, with subsequent subfertility in those women that wish to conceive.The etiology of PCOS is unclear. Early diagnosis and treatment may reduce the risk of long-term complications such as type 2 diabetes and heart disease ,PCOS affects 5-20% of women of reproductive age worldwide. The condition is characterize...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All patient age from 18to 30 Waist hip ratio \>.9
- Exclusion Criteria:
- • thyroid disorders. Hepatic diseases. Skin or bleeding disorders. Chronic disease or illnessCardiovascular and pulmonary disease,Cancer diseases., Renal failure disease. Recent surgery. hose with pacemakers or surgical implants. Musculoskeletal problems that would limit WBV.Raynaud's phenomenon. A rare condition in which cold temperatures can impede blood flow to the fingers and toes. Other conditions that pose a risk include,Pregnancy or breast-feeding,Inflammatory skin disorders,Skin conditions caused by immune system disorders, such as eczema or psoriasis
About Sabrin Mohamed Taha Abdelwahab
Sabrin Mohamed Taha Abdelwahab is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on delivering high-quality, evidence-based solutions, Sabrin oversees the design, implementation, and management of clinical trials across various therapeutic areas. Her expertise in regulatory compliance, patient safety, and data integrity ensures that each trial adheres to the highest standards of ethical practice and scientific rigor. Through collaboration with healthcare professionals and research institutions, Sabrin strives to contribute to the development of effective treatments that improve patient outcomes and enhance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bilbeis, Sharqia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported